Lysophosphatidylcholine activates mitogen-activated protein kinases by a tyrosine kinase-dependent pathway in bovine aortic endothelial cells

Atherosclerosis

Volumn 143, Issue 2, 1999, Pages 261-266

  Ozaki, Harunobu ^a   Ishii, Kenji ^a   Arai, Hidenori ^a   Kume, Noriaki ^a   Kita, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

C Jun N terminal protein kinase; Extracellular signal regulated protein kinase; Lysophosphatidylcholine; Tyrosine kinase

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PROTEIN KINASE; PROTEIN TYROSINE KINASE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CATTLE; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; BENZOQUINONES; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CATTLE; CELLS, CULTURED; CHROMATOGRAPHY, GEL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LACTAMS, MACROCYCLIC; LYSOPHOSPHATIDYLCHOLINES; MEMBRANE POTENTIALS; MITOGEN-ACTIVATED PROTEIN KINASES; QUINONES; SIGNAL TRANSDUCTION;

EID: 0032895452     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00297-4     Document Type: Article

References (41)

1. Vidaver G.A., Ting A., Lee J.W. Evidence that lysolecithin is an important causal agent of atherosclerosis. J Theor Biol. 115:1985;27-41.
2. Vadas P., Pruzanski W. Role of secretory phospholipases A2 in the pathobiology of disease. Lab Invest. 55:1986;391-404.
3. Yuan Y., Jackson S.P., Newnham H.H., Mitchell C.A., Salem H.H. An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2. Blood. 86:1995;4166-4174.
4. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity [see comments]. New Engl J Med. 320:1989;915-924.
5. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
6. Parthasarathy S., Steinbrecher U.P., Barnett J., Witztum J.L., Steinberg D. Essential role of phospholipase A2 activity in endothelial cell-induced modification of low density lipoprotein. Proc Natl Acad Sci USA. 82:1985;3000-3004.
7. Portman O.W., Alexander M. Lysophosphatidylcholine concentrations and metabolism in aortic intima plus inner media: effect of nutritionally induced atherosclerosis. J Lipid Res. 10:1969;158-165.
8. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
9. Kume N., Gimbrone Jr M.A. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 93:1994;907-911.
10. Nakano T., Raines E.W., Abraham J.A., Klagsbrun M., Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA. 91:1994;1069-1073.
11. Zembowicz A., Tang J.L., Wu K.K. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem. 270:1995;17006-17010.
12. Zembowicz A., Jones S.L., Wu K.K. Induction of cyclooxygenase-2 in human umbilical vein endothelial cells by lysophosphatidylcholine. J Clin Invest. 96:1995;1688-1692.
13. Chen Y., Morimoto S., Kitano S., Koh E., Fukuo K., Jiang B., Chen S., Yasuda O., Hirotani A., Ogihara T. Lysophosphatidylcholine causes Ca2+influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells. Atherosclerosis. 112:1995;69-76.
14. Sasaki Y., Asaoka Y., Nishizuka Y. Potentiation of diacylglycerol-induced activation of protein kinase C by lysophospholipids. Subspecies difference. FEBS Lett. 320:1993;47-51.
15. Flavahan N.A. Lysophosphatidylcholine modifies G protein-dependent signaling in porcine endothelial cells. Am J Physiol. 264:1993;722-727.
16. Davis R.J. MAPKs: new JNK expands the group. Trends Biochem Sci. 19:1994;470-473.
17. Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 9:1992;383-391.
18. Howe L.R., Marshall C.J. Lysophosphatidic acid stimulates mitogen-activated protein kinase activation via a G-protein-coupled pathway requiring p21ras and p74raf-1. J Biol Chem. 268:1993;20717-20720.
19. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.J. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
20. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
21. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
22. Han J., Lee J.D., Bibbs L., Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 265:1994;808-811.
23. Chai Y.C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J Biol Chem. 271:1996;17791-17797.
24. Marshall C.J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 80:1995;179-185.
25. Vouret-Craviari V., Van Obberghen-Schilling E., Scimeca J., Van Obberghen E., Pouyssegur J. Differencial activation of p44mapk(ERK1) by alpha-thrombin and thrombin-receptor peptide agonist. Biochem J. 289:1993;209-214.
26. Wan Y., Kurosaki T., Huang X.Y. Tyrosine kinases in activation of the MAP kinase cascade by G-protein-coupled receptors. Nature. 380:1996;541-544.
27. Daub H., Weiss F.U., Wallasch C., Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature. 379:1996;557-560.
28. Tokiwa G., Dikic I., Lev S., Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science. 273:1996;792-794.
29. Ochi H., Kume N., Nishi E., Kita T. Elevated levels of cAMP inhibit protein kinase C - independent mechanisms of endothelial platelet-derived growth factor-B chain and intercellular adhesion molecule-1 gene induction by lysophosphatidylcholine. Circ Res. 77:1995;530-535.
30. Fang X., Gibson S., Flowers M., Furui T., Bast Jr R., Mills G. Lysophosphatidylcholine stimulates activator protein 1 and the c-jun N-terminal kinase activity. J Biol Chem. 272:1997;13683-81369.
31. Venable M.E., Lee J.Y., Smyth M.J., Bielawska A., Obeid L.M. Role of ceramide in cellular senescence. J Biol Chem. 270:1995;30701-30708.
32. Modur V., Zimmerman A.G., Prescott M.S., McIntyre M.T. Endothelial cell inflammatory resposes to tumor necrosis factor alpha. J Biol Chem. 271:1996;13094-13102.
33. Yamakawa T., Eguchi S., Yamakawa Y., Motley D.E., Umaguchi K., Utsunomiya H., Inagami T. Lysophosphatidylcholine stimulates MAP kinase activity in rat vescular smooth muscle cells. Hypertension. 31:1998;248-253.
34. Tseng H., Peterson T.E., Berk B.C. Fluid shear stress stimulates mitogen-activated protein kinase in endothelial cells. Circ Res. 77:1995;869-878.
35. Li Y.S., Shyy J.Y., Li S., Lee J., Su B., Karin M., Chien S. The Ras-JNK pathway is involved in shear-induced gene expression. Mol Cell Biol. 16:1996;5947-5954.
36. Yoshizumi M., Kourembanas S., Temizer D.H., Cambria R.P., Quertermous T., Lee M.E. Tumor necrosis factor increases transcription of the heparin-binding epidermal growth factor-like growth factor gene in vascular endothelial cells. J Biol Chem. 267:1992;9467-9469.
37. Simmons D., Makgoba M.W., Seed B. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature. 331:1988;624-627.
38. Osborn L., Hession C., Tizard R., Vassallo C., Luhowskyj S., Chi Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
39. Nishida K., Harrison D.G., Navas J.P., Fisher A.A., Dockery S.P., Uematsu M., Nerem R.M., Alexander R.W., Murphy T.J. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest. 90:1992;2092-2096.
40. Herschman H.R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev. 13:1994;241-256.
41. Kume N., Cybulsky M.I., Gimbrone M.A. Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 90:1992;1138-1144.